These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. Vissing J; Haller RG N Engl J Med; 2003 Dec; 349(26):2503-9. PubMed ID: 14695410 [TBL] [Abstract][Full Text] [Related]
6. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460. Kurklinsky AK; Levy M Vasc Med; 2013 Aug; 18(4):234-6. PubMed ID: 23867841 [TBL] [Abstract][Full Text] [Related]
7. The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial. Wharton W; Stein JH; Korcarz C; Sachs J; Olson SR; Zetterberg H; Dowling M; Ye S; Gleason CE; Underbakke G; Jacobson LE; Johnson SC; Sager MA; Asthana S; Carlsson CM J Alzheimers Dis; 2012; 32(1):147-56. PubMed ID: 22776970 [TBL] [Abstract][Full Text] [Related]
8. Effects of 12 weeks of ramipril treatment on the quality of life in patients with moderate congestive heart failure: results of a placebo-controlled trial. Ramipril Study Group. Gundersen T; Wiklund I; Swedberg K; Amtorp O; Remes J; Nilsson B Cardiovasc Drugs Ther; 1995 Aug; 9(4):589-94. PubMed ID: 8547209 [TBL] [Abstract][Full Text] [Related]
9. Chronic therapy for McArdle disease: the randomized trial with ACE inhibitor. Martinuzzi A; Liava A; Trevisi E; Antoniazzi L; Frare M Acta Myol; 2007 Jul; 26(1):64-6. PubMed ID: 17915574 [No Abstract] [Full Text] [Related]
10. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Ahimastos AA; Walker PJ; Askew C; Leicht A; Pappas E; Blombery P; Reid CM; Golledge J; Kingwell BA JAMA; 2013 Feb; 309(5):453-60. PubMed ID: 23385271 [TBL] [Abstract][Full Text] [Related]
11. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials. Teo K; Yusuf S; Sleight P; Anderson C; Mookadam F; Ramos B; Hilbrich L; Pogue J; Schumacher H; Am Heart J; 2004 Jul; 148(1):52-61. PubMed ID: 15215792 [TBL] [Abstract][Full Text] [Related]
12. Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot). Babu-Narayan SV; Uebing A; Davlouros PA; Kemp M; Davidson S; Dimopoulos K; Bayne S; Pennell DJ; Gibson DG; Flather M; Kilner PJ; Li W; Gatzoulis MA Int J Cardiol; 2012 Feb; 154(3):299-305. PubMed ID: 20970202 [TBL] [Abstract][Full Text] [Related]
13. Exercise and recovery ventilatory and VO2 responses of patients with McArdle's disease. Hagberg JM; King DS; Rogers MA; Montain SJ; Jilka SM; Kohrt WM; Heller SL J Appl Physiol (1985); 1990 Apr; 68(4):1393-8. PubMed ID: 2347781 [TBL] [Abstract][Full Text] [Related]
14. Dantrolene sodium does influence the second-wind phenomenon in McArdle's disease. Electrophysiological evidence during exercise in a double-blind placebo-controlled, cross-over study in 5 patients. Poels PJ; Braakhekke JP; Joosten EM; Stegeman DF J Neurol Sci; 1990 Dec; 100(1-2):108-12. PubMed ID: 2089128 [TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study. Therrien J; Provost Y; Harrison J; Connelly M; Kaemmerer H; Webb GD Int J Cardiol; 2008 Sep; 129(2):187-92. PubMed ID: 18672299 [TBL] [Abstract][Full Text] [Related]
16. Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril. MacMahon S; Sharpe N; Gamble G; Clague A; Mhurchu CN; Clark T; Hart H; Scott J; White H J Am Coll Cardiol; 2000 Aug; 36(2):438-43. PubMed ID: 10933355 [TBL] [Abstract][Full Text] [Related]
17. Muscle pain in myophosphorylase deficiency (McArdle's disease): the role of gender, genotype, and pain-related coping. Rommel O; Kley RA; Dekomien G; Epplen JT; Vorgerd M; Hasenbring M Pain; 2006 Oct; 124(3):295-304. PubMed ID: 16793208 [TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial of angiotensin-converting enzyme inhibitor, ramipril, in patients with intermittent claudication. Shahin Y; Cockcroft JR; Chetter IC Br J Surg; 2013 Aug; 100(9):1154-63. PubMed ID: 23842829 [TBL] [Abstract][Full Text] [Related]
19. Improved energy kinetics following high protein diet in McArdle's syndrome. A 31P magnetic resonance spectroscopy study. Jensen KE; Jakobsen J; Thomsen C; Henriksen O Acta Neurol Scand; 1990 Jun; 81(6):499-503. PubMed ID: 2220306 [TBL] [Abstract][Full Text] [Related]
20. Impairment of the exercise-induced increase in muscle perfusion in McArdle's disease. Jehenson P; Leroy-Willig A; de Kerviler E; Merlet P; Duboc D; Syrota A Eur J Nucl Med; 1995 Nov; 22(11):1256-60. PubMed ID: 8575473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]